Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
- PMID: 32769897
- PMCID: PMC7593036
- DOI: 10.1097/MD.0000000000021560
Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
Abstract
Breast cancer and ovarian cancer are closely related. The major common risk factors of these 2 types of cancer are likely genetic factors. However, few studies have shown any common characteristics in patients who have both types of these 2 cancers. The purpose of this retrospective study is to explore the clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.A cohort of patients who had a history of both primary breast cancer and primary ovarian cancer were enrolled, and they received treatment in the Peking Union Medical College Hospital between January 1, 2010, and December 31, 2018. Both descriptive statistics analysis and survival analysis were performed for analysis.A total of 114 patients with both primary breast cancer and primary ovarian cancer were included in the study. The median (range) follow-up was 129.5 (20-492) months. The average interval time between the diagnosis of 2 types of cancer was 79.4 months in patients having ovarian cancer firstly and was 115.9 months in patients having breast cancer firstly. The 5- and 10-year overall survival (OS) rates were 91.5% and 81.7% for patients with ovarian cancer following breast cancer, respectively, and 90.6% and 87.5% for patients with breast cancer following ovarian cancer, respectively. Multivariate analysis revealed that independent predictors of OS were the age of diagnosis of the first tumor and the time interval between two types of tumor in patients with ovarian cancer following breast cancer.Most breast cancer or ovarian cancer occurred within 5 years after being diagnosed with the first tumor, and the interval time was significantly shorter in patients with previous ovarian cancer. The prognosis is likely positively correlated to the interval time between the occurrences of two types of cancer.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






Similar articles
-
Survival Outcomes of Patients with Primary Breast Cancer Following Primary Ovarian Cancer.Med Sci Monit. 2019 May 24;25:3869-3879. doi: 10.12659/MSM.914163. Med Sci Monit. 2019. PMID: 31125329 Free PMC article.
-
[Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):816-822. doi: 10.3760/cma.j.issn.0529-567x.2018.12.004. Zhonghua Fu Chan Ke Za Zhi. 2018. PMID: 30585019 Chinese.
-
Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.J Obstet Gynaecol Res. 2015 Nov;41(11):1813-9. doi: 10.1111/jog.12826. Epub 2015 Sep 14. J Obstet Gynaecol Res. 2015. PMID: 26369625
-
Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.Cancer. 1992 Oct 15;70(8):2129-36. doi: 10.1002/1097-0142(19921015)70:8<2129::aid-cncr2820700820>3.0.co;2-u. Cancer. 1992. PMID: 1394042
-
[Clinical analysis of 91 cases of hereditary breast and ovarian cancer].Zhonghua Zhong Liu Za Zhi. 2005 Apr;27(4):245-7. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15949430 Chinese.
Cited by
-
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer.J Gynecol Oncol. 2024 Jul;35(4):e51. doi: 10.3802/jgo.2024.35.e51. Epub 2024 Jan 12. J Gynecol Oncol. 2024. PMID: 38246184 Free PMC article.
-
Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review.Front Oncol. 2022 Jun 8;12:840431. doi: 10.3389/fonc.2022.840431. eCollection 2022. Front Oncol. 2022. PMID: 35756608 Free PMC article. Review.
-
A Multilabel Text Classifier of Cancer Literature at the Publication Level: Methods Study of Medical Text Classification.JMIR Med Inform. 2023 Oct 5;11:e44892. doi: 10.2196/44892. JMIR Med Inform. 2023. PMID: 37796584 Free PMC article.
-
Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns.Sultan Qaboos Univ Med J. 2025 May 2;25(1):499-505. doi: 10.18295/2075-0528.2863. eCollection 2025. Sultan Qaboos Univ Med J. 2025. PMID: 40657466 Free PMC article.
-
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand: a cost-effective policy in resource-limited settings.Front Public Health. 2023 Dec 14;11:1257668. doi: 10.3389/fpubh.2023.1257668. eCollection 2023. Front Public Health. 2023. PMID: 38162618 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7–34. - PubMed
-
- DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019;69:438–51. - PubMed
-
- Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115–32. - PubMed
-
- Cluze C, Delafosse P, Seigneurin A, et al. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study. Eur J Cancer Prev 2009;18:343–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical